SCHEMBL7051578

SCHEMBL7051578

Clc1cccc(CC2CO2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PNMT P11086 2/20 0.48
TAAR1 Q96RJ0 5/20 0.46
SIGMAR1 Q99720 1/20 0.44
CYP3A4 P08684 2/20 0.44
IDO1 P14902 2/20 0.44
AGXT P21549 2/20 0.44
GLA P06280 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
GAA P10253 1/20 0.43
MAPT P10636 1/20 0.43
HTT P42858 1/20 0.43
ATM Q13315 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HTR3E A5X5Y0 2/20 0.42
HTR3B O95264 2/20 0.42
HTR3A P46098 2/20 0.42
HTR3D Q70Z44 2/20 0.42
HTR3C Q8WXA8 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7142635 0.86 ALDH1A1 (0.45) CYP3A4ALDH1A1SMN1; SMN2
Water SCHEMBL28905301 0.84 ALDH1A1 (0.44) CYP3A4ALDH1A1SMN1; SMN2
SCHEMBL2514751 0.83 TAAR1 (0.49) PNMTTAAR1CYP3A4GLAKDM4E
SCHEMBL1499422 0.81 TAAR1 (0.57) PNMTTAAR1SIGMAR1CYP3A4IDO1
SCHEMBL29432882 0.81 TAAR1 (0.57) PNMTTAAR1SIGMAR1CYP3A4IDO1
SCHEMBL31490496 0.81 TSHR (0.39) CYP3A4ALDH1A1SMN1; SMN2
SCHEMBL29910956 0.79 PNMT (0.47) PNMTTAAR1SIGMAR1CYP3A4IDO1
SCHEMBL9320416 0.78 TAAR1 (0.44) PNMTTAAR1SIGMAR1CYP3A4IDO1
SCHEMBL8857144 0.78 CYP3A4 (0.50) PNMTTAAR1CYP3A4IDO1AGXT
SCHEMBL1552434 0.77 HTR2B (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130029980-A1 FLAVIN DERIVATIVES COISH PHILIP D G (US) 2013-01-31 US disclosed
EP-0611826-B1 Processes for production of optically active epoxides DAICEL CHEM (JP) 2003-05-02 EP disclosed
US-5672504-A TREATING MIXED EPOXIDE ENANTIOMORPHS WITH MICROORGANISMS TO INCREASE CONCENTRATION OF OPTICALLY PURE S-ENANTIOMORPHS DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1997-09-30 US disclosed
EP-0611826-A2 Processes for production of optically active epoxides DAICEL CHEMICAL INDUSTRIES, LTD. (JP) 1994-08-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130029980-A1 FLAVIN DERIVATIVES BLVRB, FLAD1, FDPS PNMT 2757/4885TAAR1 3574/4885SIGMAR1 2273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.